Abstract
Current attempts to treat idiopathic Parkinson’s disease (PD) and parkinsonism with transplants of dopaminergic tissue began in the 1970s, with the grafting of tissue into animal models of parkinsonism. The history of brain transplantation, however, is over a century old, dating at least back to the unsuccessful attempts by W.G. Thompson in 1890 to transplant adult cortex to adult cortex in cats and dogs (1). Table 1 lists some of the research precursors of modern fetal tissue efforts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thompson, W. G. (1890) Successful brain grafting. NY Med. J. 51, 701–702.
Dunn, E. H. (1917) Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat. J. Comp. Neurol. 27, 565–582.
Halász, B., Pupp, L., and Uhlarik, S. (1962) Hypophysiotrophic area in the hypothalamus. J. Endocr. 25, 147–159.
Stenevi, U., Björklund, A., and Svengaard, N. A. (1976) Transplantation of central and peripheral monamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res. 114, 1–20.
Björklund, A. and Stenevi, U. (1979) Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res. 177, 555–560.
Perlow, M. J., Freed, W. J., Hoffer, B. J., Seiger, Å., Olson, L., and Wyatt, R. J. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigro-striatal dopamine system. Science 204, 643–647.
Backlund, E.-O., Grandberg, P.-O., Hamberger, B., et al. (1985) Transplantation of adrenal medullary tissue to striatum in parkinsonism: first clinical trials. J. Neurosurg. 62, 169–173.
Jiang, N., Jiang, C., Tang, Z., et al. (1987) Human foetal brain transplant trials in the treatment of Parkinsonism. Acta Acad. Med. Shangai 14, 77.
Brundin, P., Duan, W. M., and Sauer, H. (1994) Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. In: Functional Neural Transplantation (Dunnett, S. B. and Björklund, A., eds.), Raven Press, New York, pp. 9–46.
Dunnett, S. B. (1998) Repair of the damaged brain. The Alfred Meyer memorial lecture 1998. Neuropath. App. Neurobiol. 25, 351–362.
Björklund, A. (1992) Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2, 683–689.
Annett, L. E. (1994) Functional studies of neural grafts in parkinsonian primates. In: Functional Neural Transplantation (Dunnett, S. B. and Björklund, A., eds.), Raven Press, New York, pp. 71–101.
Krzysztof, S., Plunkett, R. J., Jacobowitz, D. M., Kopin, I. J., and Oldfield, E. H. (1991) Fetal nondopaminergic neural implants in parkinsonian primates. J. Neurosurg. 74, 97–104.
Freed, W. J. (1983) Functional brain tissue transplantation: reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts with a note on intracranial retinal grafts. Biol. Psychiatry 18, 1205–1267.
Bohn, M. C., Marciano, F., Cupit, L., and Gash, D. M. (1988) Recovery of dopaminergic fibers in striatum of the MPTP treated mouse is enhanced by grafts of adrenal medulla. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 535–542.
Bankiewicz, K. S., Plunkett, R. J., Kopin, I. J., Jacobowitz, D. M., London, W. T., and Oldfield, E. H. (1988) Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 543–549.
Madrazo, I., Drucker-Colin, R., Diaz, V., Martinez-Marta, J., Torres, C., and Becerril, J. J. (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med. 316, 831–834.
Fahn, S. (1988) Status of transplantation in patients with Parkinson’s disease. American Neurological Association, Soriano Lecture. Philadelphia, PA.
Jiao, S., Zhang, W., Cao, J., Zhang, Z., Wang, H., Ding, M., Zhang Zhuo, Sun, J., Sun, Y., and Shi, M. (1988) Study of adrenal medullary tissue transplantation to striatum in parkinsonism. In: Progress in Brain Research, vol. 78 (Gash, D. M. and Sladek, J. R., eds.), Elsevier, Amsterdam, pp. 575–580.
Allen, G. S., Burns, R. S., Tulipan, N. B., and Parker, R. A. (1989) Adrenal medullary transplantation to the caudate nucleus in Parkinson’s disease. Arch. Neurol. 46, 487–491.
Goetz, C. G., Tanner, C. M., Penn, R. D., Stebbins, G. T., Gilley, D. W., Shannon, K. M., et al. (1990) Adrenal medullary transplant to the striatum of patients with advanced Parkinson’s disease: 1-year motor and psychomotor data. Neurology 40, 273–276.
Velasco, F., Velasco, M., Cuevas, H. R., Jurado, J., Olvera, J., and Jiménez, F. (1991) Autologous adrenal medullary transplants in advanced Parkinson’s disease with particular attention to the selective improvement in symptoms. Stereotact. Funct. Neurosurg. 57, 195–212.
Goetz, C. G., Stebbins, G. T., Klawans, H. L., Koller, W. C., Grossman, R. G., Bakay, R. A. E., Penn, R. D., and UPF Neural Transplantation Registry. (1991) United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants: presurgical and 1- and 2-year follow-up. Neurology 41, 1719–1722.
Peterson, D. I., Price, M. L., and Small, C. S. (1989) Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson’s disease. Neurology 39, 235–238.
Forno, L. S. and Langston, J. W. (1989) Adrenal medullary transplant to the brain for Parkinson’s disease. Neuropathology of an unsuccessful case. J. Neuropathol. Exp. Neurol. 48(Abstr.), 339.
Hirsch, E. C., Duyckaerts, C., Javoy-Agid, F., Hauw, J.-J., and Agid, Y. (1990) Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson’s disease? Ann. Neurol. 27, 676–682.
Strada, O., Hirsch, E. C., Javoy-Agid, F., Duyckaerts, C., Hauw, J.-J., and Agid, Y. (1993) Low affinity nerve growth factor receptor, adrenal transplant and Parkinson’s disease. J. Neurol. Sci. 120, 33–37.
Hurtig, H., Joyce, J., Sladek, J. R., and Trojanowski, J. Q. (1989) Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson’s disease. Ann. Neurol. 25, 607–614.
Kordower, J. H., Cochran, E., Penn, R. D., and Goetz, C. G. (1991) Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson’s disease. Ann. Neurol. 29, 405–412.
Waters, C., Itabashi, H. H., Apuzzo, M. L. J., and Weiner, L. P. (1990) Adrenal to caudate transplantation: postmortem study. Mov. Disord. 5, 248–250.
Dohan, F. C., Robertson, J. T., Feler, C., Schweitzer, J., Hall, C., and Robertson, J. H. (1988) Autopsy findings in a Parkinson’s disease patient treated with adrenal medullary to caudate nucleus transplant. Soc. Neurosci. Abstr. 1, 8.
Fazzini, E., Dwork, A. J., Blum, C., Burke, R., Coté, L., Goodman, R. R., et al. (1991) Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. Arch. Neurol. 48, 813–820.
Jankovic, J., Grossman, R., Goodman, C., Pirozzolo, F., Schneider, L., Zhu, Z., et al. (1989) Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson’s disease. Neurology 39, 1227–1234.
Lindvall, O., Rehncrona, S., Gustavii, B., Brundin, P., Astedt, B., Widner, H., et al. (1988) Fetal dopamine-rich mesencephalic grafts in Parkinson’s disease. Lancet 2, 1483–1484.
Madrazo, I., Leon, V., Torres, C., Aguilera, M. C., Varela, G., Alvarez, F., et al. (1988) Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. N. Engl. J. Med. 318, 51.
Lindvall, O. (1998) Update on fetal transplantation: the Swedish experience. Mov. Disord. 13(Suppl. 1), 83–87.
Freeman, T. B., Hauser, R. A., and Sanberg, P. R. (1999) Fatal transplant cyst. J. Neurosurg. 90, 1148–1150.
Freeman, T. B., Sanberg, P. R., Nauert, G. M., Boss, B. D., Spector, D., Olanow, C. W., and Kordower, J. H. (1995) Influence of donor age on the survival of solid and suspension intraparenchymal human embryonic micrografts. Cell Transplant. 4, 141–154.
Freeman, T. B., Spence, M. S., Boss, B. D., Spector, D. H., Strecker, R. E., Olanow, C. W., and Kordower, J. H. (1991) Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113, 344–353.
Verney, C., Zecevic, N., Nikolic, B., Alvarez, C., and Berger, B. (1991) Early evidence of catecholaminergic cell groups in 5- and 6–233k-old human embryos using tyrosine hydroxylase and dopamine-B-hydroxylase immunocytochemistry. Neurosci. Lett. 131, 121–124.
Spencer, D. D., Robbins, R. J., Narftolin, F., Marek, K. L., Vollmer, T., Leranth, C., et al. (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson’s disease. N. Engl. J. Med. 327, 1541–1548.
Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., Zi, J.-X., et al. (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N. Engl. J. Med. 327, 1549–1555.
Freeman, T. B., Olanow, C. W., Hauser, R. A., Nauert, G. M., Smith, D. A., Borlongan, C. V., et al. (1995) Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson’s disease. Ann. Neurol. 38, 379–388.
Pakkenberg, B., Moller, A., Gunderson, H. J., Mouritzen Dam, A., and Pakkenberg, H. (1991) The absolute number of nerve cells in the substantia nigra of normal subjects and in patients with Parkinson’s disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 54, 30–33.
Brundin, P., Strecker, R. E., Clarke, D. J., Widner, H., Nilsson, O. G., Astedt, B., Lindvall, O., and Bjorklund, A. (1988) Can human fetal dopamine neuron grafts provide a therapy for Parkinson’s disease. Prog. Brain Res. 78, 441–448.
Brundin, P., Strecker, R. E., Widner, H., Clarke, D. J., Nilsson, O. G., Astedt, B., Lindvall, O., and Bjorklund, A. (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson’s disease: immunological aspects, spontaneous and drug-induced behaviour and dopamine release. Exp. Brain Res. 70, 192–208.
Kordower, J. K., Rosenstein, R. M., Collier, T. J., Burke, M. A., Chen, E.-Y., Li, J. M., et al. (1996) Functional fetal nigral grafts in a patient with Parkinson’s disease: chemoanatomic, ultrastructural and metabolic studies. J. Comp. Neurol. 370, 203–230.
Peschanski, M., Defer, G., N’Guyen, J. P., Ricolfi, F., Monfort, J. C., Remy, P., et al. (1994) Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson’s disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117, 487–499.
Madrazo, I., Franco-Bourland, R., Ostrosky-Solis, F., Aguilera, M., Cuevas, C., Zamorano, C., et al. (1990) Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects. Arch. Neurol. 47, 1281–1285.
Molina, H., Quinones, R., Alvarez, L., Galarrage, J., Piedra, J., Suarez, C., et al. (1991) Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson’s disease: the Cuban experience. In: Intracerebral Transplantation in Movement Disorders (Lindvall, O., Bjorklund, A., and Widner, H., eds.), Elsevier Science Publishers, Amsterdam, pp. 99–110.
Lopez-Lozano, J. J., Bravo, G., Brera, B., Millan, I., Dargallo, J., Salmean, J., Uria, J., Insausti, J., and the Clinica Puerta de Hierro neural transplantation group. (1997) Long-term improvement in patients with severe Parkinson’s disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. J. Neurosurg. 86, 931–942.
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., et al. (2001) Embryonic dopamine cell transplantation for advanced Parkinson’s disease: a double-blind neurosurgical trial. N. Engl. J. Med. 344, 710–719.
Henderson, B. T., Clough, C. G., Hughes, R. C., Hitchcock, E. R., and Kenny, B. G. (1991) Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson’s disease. Arch. Neurol. 48, 822–827.
Kordower, J. H., Styren, S., Clarke, M., DeKoskey, S. T., Olanow, C. W., and Freeman, T. B. (1997) Fetal grafting for Parkinson’s disease: expression of immune markers in two patients with functional fetal nigral implants. Cell Transplant. 6, 213–219.
Langston, J. W., Widner, H., Goetz, C. G., Brooks, D., Fahn, S., Freeman, T., and Watts, R. (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. 7. 2–13.
Defer, G. L., Widner, H., Marie, R. M., Remy, P., and Levivier, M. (1999) Core assessment program for surgical interventional therapies in parkinson’s disease (CAPSIT-PD). Mov. Disord. 14, 572–584.
Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., et al. (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327, 1556–1563.
Wenning, G. K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., et al. (1997) Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson’s disease. Ann. Neurol. 42, 95–107.
Hauser, R. A., Freeman, T. B., Snow, B. J., Nauert, M., Gauger, L., Kordower, J. H., and Olanow, C. W. (1999) Longterm evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56, 179–187.
Defer, G.-L., Geny, C., Ricolfi, F., Fenelon, G., Monfort, J.-C., Remy, P., et al. (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. Brain 119, 41–50.
Kopyov, O. V., Jacques, D., Lieberman, A., Duma, C. M., and Rogers, R. L. (1996) Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson’s disease. Cell Transplant. 5, 327–337.
Kopyov, O. V., Jacques, D., Lieberman, A., Duma, C. M., and Rogers, R. L. (1997) Outcome following intrastriatal fetal mesencephaoic grafts for Parkinson’s patients is directly related to the volume of grafted tissue. Exp. Neurol. 146, 536–545.
Subrt, O., Tichy, M., Vladyka, V., and Hurt, K. (1991) Grafting of fetal dopamine neurons in Parkinson’s disease: the Czech experience with severe akinetic patients. Acta Neurochirurg. Suppl. 52, 51–53.
Iacono, R. P., Tang, Z. S., Mazziotta, J. C., Grafton, S., and Hoehn, M. (1992) Bilateral fetal grafts for Parkinson’s disease: 22 months’ results. Stereotact. Funct. Neurosurg. 58, 84–87.
Levivier, M., Dethy, S., Rodesch, F., Peschanski, M., Vandesteene, A., David, P., et al. (1997) Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson’s disease. Stereotact. Funct. Neurosurg. 69, 99–111.
Mendez, I., Dagher, A., Hong, M., Hebb, A., Gaudet, P., Law, A., et al. (2000) Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson’s disease. J. Neurosurg. 92, 863–869.
Benabid, A. L., Pollak, P., Gao, D., Hoffmann, D., Limousin, P., Gay, E., et al. (1996) Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J. Neurosurg. 84, 203–214.
Folkerth, R. D. and Durso, R. (1996) Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles. in a parkinsonian patient treated with fetal allografts. Neurology 46, 1219–1225.
Mamelak, A. N., Eggerding, F. A., Oh, D. S., Wilson, E., Davis, R. L., Spitzer, R., et al. (1998) Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson’s disease. J. Neurosurg. 89, 592–598.
Redmond. D. E. Jr.. Leranth, C., Spencer, D. D., et al. (1990) Fetal neural graft survival. Lancet 336, 820–822.
Hitchcock, E. H., Whitewell, H. L., Sofroniew, M. V., and Bankiewicz, K. S. (1994) Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson’s disease after intrastriatal grafting of fetal ventral mesencephalon (Abs). Exp. Neurol. 129, 3.
Freed, C. R., Trojanowski, J. Z., Galvin, J. E., Rosenstein, J. M., Breeze, R. E., Greene, P. E., et al. (1997) Embryonic dopamine cells cultured as strands show long term survival without immunosuppression in a patient with advanced Parkinson’s disease. Soc. Neurosci. Abstr. 23, 1682.
Kordower, J. H., Freeman, T. B., and Olanow, C. W. (1998) Neuropathology of fetal nigral grafts in patients with Parkinson’s disease. Mov. Disord. 13(Suppl. 1), 88–95.
Lawson, H. W., Atrash, H. K., Saftlas, A. F., Koonin, L. M., Ramick, M., and Smith, J. C. (1988) Abortion surveillance, US 1984–1985. Morbid. Mortal. Wkly Rep. 38, 11–42.
Rosenblad, C., Martinez-Serrano, A., and Bjorklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75, 979–985.
Granholm, A.-C., Mott, J. L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B. J., et al. (1997) Glial cell lin-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res. 116, 29–38.
Yurek, D. M., Lu, W., Hipkens, S., and Wiegand, S. J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137, 105–118.
Espejo, M., Cutillas, B., Arenas, E., and Ambrosio, S. (2000) Increased sruvival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant. 9, 45–53.
Bjorklund, A., Spenger, C., and Stromberg, I. (1997) Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model. Exp. Neurol. 148, 324–333.
Schierle, G. S. K., Hansson, O., and Brundin, P. (1999) Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience 94, 17–20.
Deacon, T., Schumacher, J., Dinsmore, J., et al. (1997) Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s disease. Nature Med. 3, 350–353.
Schumacher, J. M., Ellias, S. A., Palmer, E. P., Kott, H. S., Dinsmore, J., Dempsey, P. K., et al. (2000) Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54, 1042–1050.
Watts, R. L., Freeman, T. L., Hauser, R. A., Bakay, R. A., Ellias, S. A., Stoessl, A. J., et al. (2001) A double-blind, randomized, controlled, multicenter clinical trial of the safety and efficacy of stereotaxic intrastriatal implantation of fetal porcine ventral mesencephalic tissue (NeurocellTM-PD) vs. imitation surgery in patients with Parkinson’s disease (PD). Parkinsonism Rel. Disord. 7(Suppl.), S87.
Patience, C., Takenchi, Y., and Weiss, R. A. (1997) Infection of human cells by an endogenous retrovirus of pigs. Nature Med. 3, 282–286.
Bankiewicz, K. S., Leff, S. E., Nagy, D., Jungles, S., Rokovich, J., Spratt, K., et al. (1997) Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson’s disease. Exp. Neurol. 144, 147–156.
Date, I. and Ohmoto, T. (1999) Neural transplantation for Parkinson’s disease. Cell Mol. Neurobiol. 19, 67–78.
Uchida, K., Roach, A. H., Kawaja, M. D., and Toya, S. (1999) Successful survival of grafted transgenic neural plate cells in adult central nervous system environment. Cell Mol. Neurobiol. 19, 79–86.
Bentlage, C., Nikkhah, G., Cunningham, M. G., and Bjorklund, A. (1999) Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp. Neurol. 159, 177–190.
Dunnett, S. B., Rogers, D. C., and Richards, S.-J. (1989) Nigrostriatal reconstruction after 6-OHDA lesion in rats: combination of dopamine-rich nigral grafts and nigrostriatal “bridge” grafts. Exp. Brain Res. 75, 523–535.
Zhou, F. C. and Chiang, Y. H. (1995) Excitochemical-induced trophic bridging directs axonal growth of transplanted neurons to distal target. Cell Transplant. 4, 103–112.
Mendez, I., Sadi, D., and Hong, M. (1996) Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J. Neurosci. 16, 7216–7227.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Greene, P., Fahn, S. (2003). Fetal Tissue Transplantation for the Treatment of Parkinson’s Disease. In: Tarsy, D., Vitek, J.L., Lozano, A.M. (eds) Surgical Treatment of Parkinson’s Disease and Other Movement Disorders. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-312-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-59259-312-5_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9736-6
Online ISBN: 978-1-59259-312-5
eBook Packages: Springer Book Archive